{"id":"https://openalex.org/W7060901116","doi":null,"title":"Parp-1 In Parkinson\u2019s Disease: From Molecular And Cellular Mechanisms To Therapeutic Strategies","display_name":"Parp-1 In Parkinson\u2019s Disease: From Molecular And Cellular Mechanisms To Therapeutic Strategies","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W7060901116"},"language":"en","primary_location":{"id":"pmh:oai:repository.upenn.edu:edissertations-5869","doi":null,"is_oa":true,"landing_page_url":"https://repository.upenn.edu/cgi/viewcontent.cgi?article=5869&context=edissertations","pdf_url":"https://repository.upenn.edu/edissertations/4083","source":{"id":"https://openalex.org/S4306402083","display_name":"ScholarlyCommons (University of Pennsylvania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79576946","host_organization_name":"University of Pennsylvania","host_organization_lineage":["https://openalex.org/I79576946"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Publicly Accessible Penn Dissertations","raw_type":"text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://repository.upenn.edu/edissertations/4083","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069923599","display_name":"Laura N. Puentes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Puentes, Laura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5069923599"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9326000213623047,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9326000213623047,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.04830000177025795,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parp-1","display_name":"PARP1","score":0.9700000286102295},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9319999814033508},{"id":"https://openalex.org/keywords/poly-adp-ribose","display_name":"poly(ADP-ribose)","score":0.8809999823570251},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.8650000095367432},{"id":"https://openalex.org/keywords/neuronal-death","display_name":"neuronal cell death","score":0.6449999809265137},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.7599999904632568},{"id":"https://openalex.org/keywords/parp1-inhibitors","display_name":"PARP-1 inhibitors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.5839999914169312},{"id":"https://openalex.org/keywords/treatment-strategy","display_name":"treatment options","score":0.5740000009536743}],"concepts":[{"id":"https://openalex.org/C144251240","wikidata":"https://www.wikidata.org/wiki/Q7068229","display_name":"Nucleofection","level":4,"score":0.4099999964237213},{"id":"https://openalex.org/C2778283623","wikidata":"https://www.wikidata.org/wiki/Q18032200","display_name":"TSG101","level":5,"score":0.32170000672340393},{"id":"https://openalex.org/C2777158700","wikidata":"https://www.wikidata.org/wiki/Q1419356","display_name":"Hyporeflexia","level":3,"score":0.3165000081062317},{"id":"https://openalex.org/C2992336715","wikidata":"https://www.wikidata.org/wiki/Q63431143","display_name":"Gestational period","level":4,"score":0.31029999256134033},{"id":"https://openalex.org/C133074676","wikidata":"https://www.wikidata.org/wiki/Q428729","display_name":"Fusible alloy","level":2,"score":0.30090001225471497},{"id":"https://openalex.org/C18743360","wikidata":"https://www.wikidata.org/wiki/Q1208096","display_name":"Diafiltration","level":4,"score":0.2924000024795532},{"id":"https://openalex.org/C180938184","wikidata":"https://www.wikidata.org/wiki/Q2142270","display_name":"Liquation","level":3,"score":0.29089999198913574},{"id":"https://openalex.org/C2777054765","wikidata":"https://www.wikidata.org/wiki/Q6402731","display_name":"Dysgeusia","level":3,"score":0.28200000524520874},{"id":"https://openalex.org/C145741570","wikidata":"https://www.wikidata.org/wiki/Q7251534","display_name":"Proteogenomics","level":5,"score":0.2768000066280365},{"id":"https://openalex.org/C2781032047","wikidata":"https://www.wikidata.org/wiki/Q938793","display_name":"Articular cartilage damage","level":5,"score":0.27090001106262207},{"id":"https://openalex.org/C2776356786","wikidata":"https://www.wikidata.org/wiki/Q1048573","display_name":"Tubulopathy","level":3,"score":0.26159998774528503},{"id":"https://openalex.org/C2779627259","wikidata":"https://www.wikidata.org/wiki/Q779763","display_name":"Pretext","level":3,"score":0.26010000705718994},{"id":"https://openalex.org/C2777935831","wikidata":"https://www.wikidata.org/wiki/Q3144949","display_name":"Hemopericardium","level":3,"score":0.2515000104904175}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:repository.upenn.edu:edissertations-5869","doi":null,"is_oa":true,"landing_page_url":"https://repository.upenn.edu/cgi/viewcontent.cgi?article=5869&context=edissertations","pdf_url":"https://repository.upenn.edu/edissertations/4083","source":{"id":"https://openalex.org/S4306402083","display_name":"ScholarlyCommons (University of Pennsylvania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79576946","host_organization_name":"University of Pennsylvania","host_organization_lineage":["https://openalex.org/I79576946"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Publicly Accessible Penn Dissertations","raw_type":"text"},{"id":"pmh:oai:repository.upenn.edu:20.500.14332/31169","doi":null,"is_oa":false,"landing_page_url":"https://repository.upenn.edu/handle/20.500.14332/31169","pdf_url":null,"source":{"id":"https://openalex.org/S4306402083","display_name":"ScholarlyCommons (University of Pennsylvania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79576946","host_organization_name":"University of Pennsylvania","host_organization_lineage":["https://openalex.org/I79576946"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"published","raw_type":"Dissertation/Thesis"}],"best_oa_location":{"id":"pmh:oai:repository.upenn.edu:edissertations-5869","doi":null,"is_oa":true,"landing_page_url":"https://repository.upenn.edu/cgi/viewcontent.cgi?article=5869&context=edissertations","pdf_url":"https://repository.upenn.edu/edissertations/4083","source":{"id":"https://openalex.org/S4306402083","display_name":"ScholarlyCommons (University of Pennsylvania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79576946","host_organization_name":"University of Pennsylvania","host_organization_lineage":["https://openalex.org/I79576946"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Publicly Accessible Penn Dissertations","raw_type":"text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7060901116.pdf","grobid_xml":"https://content.openalex.org/works/W7060901116.grobid-xml"},"referenced_works_count":3,"referenced_works":["https://openalex.org/W3008936251","https://openalex.org/W3031912651","https://openalex.org/W3036273457"],"related_works":["https://openalex.org/W3195021845","https://openalex.org/W4414568881","https://openalex.org/W3186015573","https://openalex.org/W3117160132","https://openalex.org/W2911997238","https://openalex.org/W2898743739","https://openalex.org/W3138820120","https://openalex.org/W1981421866","https://openalex.org/W2083903905","https://openalex.org/W2065439630"],"abstract_inverted_index":{"Poly":[0],"(ADP-ribose)-polymerase":[1],"1":[2],"(PARP-1)":[3],"is":[4,43,55,70,103,111,125,142],"a":[5,15,27,44,143],"DNA":[6],"repair":[7],"enzyme":[8],"that":[9,69,108,117],"has":[10,23,135],"been":[11,24],"implicated":[12],"in":[13,78,97,113,138],"regulating":[14],"number":[16,28],"of":[17,21,29,92,132],"inflammatory":[18],"processes.":[19],"Hyperactivation":[20],"PARP-1":[22,109,133,149],"linked":[25],"to":[26,72,145],"inflammation-associated":[30],"clinical":[31],"conditions,":[32],"including":[33],"cancer,":[34],"metabolic":[35],"disorders,":[36],"and":[37,52,87,116,147],"neurodegenerative":[38,46,60],"disease.":[39],"Parkinson\u2019s":[40],"disease":[41,61],"(PD)":[42],"complex":[45,157],"disorder":[47],"characterized":[48],"by":[49,74],"bradykinesia,":[50],"tremors,":[51],"rigidity.":[53],"PD":[54,93,115],"the":[56,79,85,90,98],"second":[57],"most":[58],"common":[59],"after":[62],"Alzheimer\u2019s":[63],"disease,":[64],"with":[65,152],"an":[66,165],"incidence":[67],"rate":[68],"estimated":[71],"increase":[73],"more":[75],"than":[76],"30%":[77],"next":[80],"decade.":[81],"Our":[82],"understanding":[83],"on":[84],"progression":[86],"mechanisms":[88],"underlying":[89],"onset":[91],"have":[94],"grown":[95],"enormously":[96],"past":[99],"few":[100],"decades.":[101],"There":[102],"now":[104],"growing":[105],"evidence":[106],"suggesting":[107],"hyperactivation":[110],"involved":[112],"driving":[114],"poly":[118],"(ADP-ribose)":[119],"(PAR)":[120],"-":[121],"dependent":[122],"cell":[123],"death":[124],"responsible":[126],"for":[127,156,169],"neuronal":[128],"loss.":[129],"While":[130],"inhibition":[131],"activity":[134],"proven":[136],"beneficial":[137],"cancer":[139],"therapy,":[140],"there":[141],"need":[144],"design":[146],"validate":[148],"inhibitors":[150],"(PARPi)":[151],"optimal":[153],"physicochemical":[154],"properties":[155],"neurological":[158],"conditions.":[159],"These":[160],"pharmacological":[161],"interventions":[162],"may":[163],"provide":[164],"alternative":[166],"therapeutic":[167],"approach":[168],"managing":[170],"PD.":[171]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2025-10-10T00:00:00"}